Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 5/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 5/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.38 |
| ▸ | SMPD3 | Q9NY59 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | PANK3 | Q9H999 | 1/20 | 0.36 |
| ▸ | OGA | O60502 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22795905 | 0.89 | CNR2 (0.39) | CHRNB4CHRNA3CHRNB2CHRNA4CHRM2 | |
| SCHEMBL29596859 | 0.89 | CHRM4 (0.37) | CHRNB4CHRNA3CHRNB2CHRNA4CHRM2 | |
| SCHEMBL24624329 | 0.89 | CHRM4 (0.37) | CHRNB4CHRNA3CHRNB2CHRNA4CHRM2 | |
| SCHEMBL22795641 | 0.87 | SMPD3 (0.39) | CHRNB4CHRNA3CHRNB2CHRNA4SMPD3 | |
| SCHEMBL25812286 | 0.84 | SMPD3 (0.37) | CHRNB4CHRNA3CHRNB2CHRNA4SMPD3 | |
| SCHEMBL12524364 | 0.82 | CHRM4 (0.39) | CHRNB4CHRNA3CHRNB2CHRNA4CHRM2 | |
| SCHEMBL20071399 | 0.81 | CHRNB4 (0.57) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL29597502 | 0.80 | CHRM4 (0.39) | CHRNB4CHRNA3CHRNB2CHRNA4CHRM2 | |
| SCHEMBL24623312 | 0.80 | CHRM4 (0.39) | CHRNB4CHRNA3CHRNB2CHRNA4CHRM2 | |
| Hydrochloric Acid SCHEMBL23607806 | 0.79 | CHRNB4 (0.56) | CHRNB4CHRNA3CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020248972-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF | JS INNOPHARM (SHANGHAI) LTD (CN) | 2020-12-17 | — | — | WO | disclosed |